Product Image

Contributor Information

  • Name Devanand Sarkar
  • Institute Virginia Commonwealth University
  • Primary citation Komaniecki et al. Biochemistry 62(2):543-553. PMID: 36548985

Tool Details

  • Tool name: SAR-22-097F mouse line
  • Tool type: Mouse
  • Cancer type: Carcinoma
  • Disease: Nonalcoholic Fatty Liver Disease
  • Model: Knock-In
  • CRISPR: Yes
  • Conditional: No
  • Application: RNA-Seq, Western Blot, and Immunofluorescence
  • Genetic background and cross history: AEG-1-C75S mice were created in C57BL/6/J background. ATG-1-C75S heterozygotexheterozygote mating was performed to generate AEG-1-WT adn AEG-1-C75S littermates
  • Phenotype: Unaffected litter size of AEG-1-C75S mice compared to WT adn overall showing milder and different phenotype compared to AEG-1-/- mice
  • Strain: C57BL/6/J
  • Description: Mouse line with cysteine 75 of AEG-1 mutated to serine. AEG-1-C75S mice might be more prone to developing NASH and HCC which could help design new therapeutic strategies.
    Findings identify a novel role of AEG-1 palmitoylation regulating NASH and HCC thereby establishing the rationale for using inhibitors of AEG-1 depalmitoylating enzymes for the treatment of NASH and HCC.
  • Research area: Cancer
  • Production details: Knock-in mice by CRISPR/Cas9 in which Cys75 of AEG-1 was mutated to Ser (AEG-1-C75S). AEG-1-C75S mice were created in C57BL/6/J background. ATG-1-C75S heterozygotexheterozygote mating was performed to generate AEG-1-WT adn AEG-1-C75S littermates

  • For Research Use Only

Target Details

Application Details

  • Application: RNA-Seq, Western Blot, and Immunofluorescence

Handling

Documentation

References

  •   Komaniecki et al. Biochemistry 62(2):543-553. PMID: 36548985